ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RUA Rua Life Sciences Plc

9.90
0.00 (0.00%)
04 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rua Life Sciences Plc LSE:RUA London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.90 9.80 10.00 9.90 9.90 9.90 99,729 07:48:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 2.18M -2M -0.0323 -3.07 6.14M
Rua Life Sciences Plc is listed in the Plastics,resins,elastomers sector of the London Stock Exchange with ticker RUA. The last closing price for Rua Life Sciences was 9.90p. Over the last year, Rua Life Sciences shares have traded in a share price range of 9.75p to 60.00p.

Rua Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of Rua Life Sciences is £6.14 million. Rua Life Sciences has a price to earnings ratio (PE ratio) of -3.07.

Rua Life Sciences Share Discussion Threads

Showing 3451 to 3470 of 3475 messages
Chat Pages: 139  138  137  136  135  134  133  132  131  130  129  128  Older
DateSubjectAuthorDiscuss
07/2/2024
22:17
I remember news, it used to be positive but turned negative. But at least we still had positive words, now we are reduced to cryptic messages and even they have become thin on the ground. Are we full circle yet.
One thing I can guarantee is that there are plans, probably very ambitious plans, like the one I had to retire early.

hedgehog11
07/2/2024
15:51
I now ignore all they say completely and just wait for some actual news.
harrogate
07/2/2024
15:49
Harrogate, in a word, yes!
bones
07/2/2024
13:47
Don't you find that often the words are intriguing and promising - majors visiting us etc etc - but the actions less so?
harrogate
07/2/2024
13:39
I also thought the comment in the RNS announcing Stretton's departure was intriguing, if cryptic, but opens up many possibilities of outside interest or investment:

"RUA is pursuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team."

For a development to play a part in the formation of the senior leadership team suggests something of size. Whether that comes from internal sources or outside interest (more likely) remains to be seen.

bones
07/2/2024
12:56
Thread header now updated and cleaned up to reflect current information and shareholder lists.
bones
07/2/2024
00:03
Last summer at the AGM, the RUA board said they would not dilute the other businesses by raising the money (£6M approx) needed for the Vascular graft clinical trials and instead would seek outside finance, however that might manifest itself. They confirmed that in the interims in December (but did of course raise and dilute to keep heart valve financed).

In the webinar that followed, Bill was asked in Q&A about how that was going and what action was being taken to find a buyer or partner. In near enough his words, he said:

“I’m not going to speculate on company names or people we may have been speaking to. There are potential financial backers and a potential industry backer but I’m not going to speculate on what we are doing or what the detailed processes are but we are working on it.”

My own guess based on that wording of “financial backers and an industry backer” is it could be Corcym and/or their financial backers, Gyrus Capital. That would seem to make logical sense given that Corcym are already signed up for the ultimate sales distributor role worldwide. Why would that group of backers not want to throw a relatively small sum (for them) at this and help get the vascular graft through trials and the bulk of sales into their pockets? At the moment, they have a 50/50 deal on sales but that could be skewed further to Corcym in exchange for financing the trial.

All speculation on my part but in my opinion should be the bookies favourite, if the vascular graft is ever to get off the ground!

bones
30/1/2024
16:23
Thanks Harrogate - to confirm "Grant Thornton UK LLP ("Grant Thornton") has resigned as the Group's auditor." They resign because RUA chose to replace them, is that the normal process?
hedgehog11
30/1/2024
12:14
They haven't quit they have lost the audit after a competitive tender as it says clearly. It happens and hopefully we have saved a few bob
harrogate
30/1/2024
12:00
All quiet on the comments board after todays announcement. The auditors haven't quit because the fee has shrunk, because it won't have. I doubt Caroline's exit was enough for them to quit, despite the announcement coming the day after. So why have they? Do they feel like RUA are hiding something from them, like the terms of a grant or details of the recent fund raise. Just when you think the bottom has been reached this throws up more doubt.
hedgehog11
29/1/2024
09:07
The only surprise is what took so long to announce it.
hedgehog11
29/1/2024
08:04
Seems like good news to me. Never felt she added much.
t0pgrader
29/1/2024
08:00
I don't think that anybody here is surprised by this morning's RNS !! CS has not been included in the goings on in the last 6 months or so. "Rua is persuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team". To me this indicates that the new heart valve business is starting to come to fruition and the manufacturing capability will need to be expanded. Lot's of near term news can be expected IMHO of course.
parsons4
29/1/2024
08:00
I don't think that anybody here is surprised by this morning's RNS !! CS has not been included in the goings on in the last 6 months or so. "Rua is persuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team". To me this indicates that the new heart valve business is starting to come to fruition and the manufacturing capability will need to be expanded. Lot's of near term news can be expected IMHO of course.
parsons4
29/1/2024
07:41
She didn't make any comment in the rns which usually means pushed.
babbler
29/1/2024
07:29
Understandable that she would be leaving after she did not take part in the recent fund raising. With the departure of the director for regulatory affairs a few months ago and this departure this takes about 330k costs out of the business. The above comment assumes that she is leaving voluntarily.
langland
29/1/2024
07:13
Well if She is leaving it doesn't sound like the prospects are good
amt
26/1/2024
13:41
Building up steam for another attack on that resistance level
trotterstrading
19/1/2024
16:00
Just working through the book, when they ready the MM's will let it go.. won't be long now
trotterstrading
19/1/2024
15:54
Weird pricing when bring sold this morn priced moved up blue. When being bought this after price dropped red. Any one any thoughts.
7767
Chat Pages: 139  138  137  136  135  134  133  132  131  130  129  128  Older

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com